BTD Capital Fund ETF(DIP.US)

Company Encyclopedia
View More
name
BTD Capital Fund ETF
DIP.US
News
View More

Key facts: Amgen stock hits $328.43; strong growth outlook for 2026

Amgen's stock price has reached $328.43 per share, marking a 17.6% return over the past six months, which outperforms the S&P 500 by 6.3%, driven by the company's strong quarterly results.1Amgen (AMGN) is a top pick for 2026, noted for its strong oncology and immunology portfolio, and a solid 3.08% dividend yield, positioning it well for growth.2

TradingView·
US
AMGN
-0.42%
TradingView·
US
AMGN
-0.42%

These three ‘Dogs of the Dow’ stocks are must-own for 2026

Kevin Simpson of Capital Wealth Planning highlights three ‘Dogs of the Dow’ stocks for 2026: Amgen, Verizon, and Home Depot. Amgen offers healthcare resilience with a 3.08% dividend yield, making it a solid choice for income-focused investors. Verizon, with a nearly 7% yield, is favored for its dependable cash returns despite modest growth. Home Depot, despite a recent decline, is seen as having significant rebound potential if interest rates normalize, offering a 2.66% yield and upside tied to economic recovery. These stocks are recommended for stability and income in 2026.

Invezz·
US
VZ
+0.07%
US
AMGN
-0.42%
US
HD
-0.65%
Invezz·
US
VZ
+0.07%
US
AMGN
-0.42%
US
HD
-0.65%

Amgen Inc. $AMGN Shares Acquired by Calamos Wealth Management LLC

Calamos Wealth Management LLC increased its stake in Amgen Inc. by 136.1% in Q3, owning 5,813 shares valued at $1.64 million. Other hedge funds also adjusted their positions in Amgen. The company reported Q3 earnings of $5.64 per share, exceeding estimates, with revenue of $9.56 billion. Amgen declared a quarterly dividend of $2.52, up from $2.38, with a yield of 3.1%. Insider selling occurred, with significant shares sold by executives. Amgen's stock performance shows a market cap of $176.89 billion and a P/E ratio of 25.39.

Market Beat·
US
AMGN
-0.42%
Market Beat·
US
AMGN
-0.42%

Strong results and pipeline momentum power Amgen’s (AMGN) 2025 rally

Amgen Inc. (NASDAQ:AMGN) has been recognized as one of the 14 Best Pharma Dividend Stocks to Buy in 2026. The company has shown strong financial performance and consistent clinical advancements, leading to a 27% increase in stock value this year, despite concerns over upcoming patent expirations.

MSN·
US
AMGN
-0.42%
MSN·
US
AMGN
-0.42%

C.H. Robinson Worldwide Inc. Stock Underperforms Tuesday When Compared To Competitors

C.H. Robinson Worldwide Inc. (CHRW) shares fell 1.21% to $161.96 on Tuesday, marking the third consecutive day of losses. The stock closed 3.54% below its 52-week high of $167.90. In comparison, competitors like Old Dominion Freight Line Inc. and J.B. Hunt Transport Services Inc. also experienced declines, but CHRW underperformed relative to them. The overall market saw a slight downturn, with the S&P 500 and Dow Jones Industrial Average both falling.

Dow Jones·
US
CHRW
-0.74%
Dow Jones·
US
CHRW
-0.74%
Posts
View More

and we are now down a full 5% on silver $iShares Silver Tr(SLV.US) folks

the problem is, no one knows when the trade is over

so if dip buyers dont step in and people think the trade is done because of p......
  • 0
© 2026 Longbridge｜Disclaimer